$SHPH Shuttle Pharma Doses First Patients in Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients with Glioblastoma
https://www.globenewswire.com/en/news-release...stoma.html
https://www.globenewswire.com/en/news-release...stoma.html